Hidroxymethylnitrofurazone (NFOH) in experimental Trypanosoma cruzi infections is more efficient and decrease damage in the chronic stage than acute stage

Vol. 1, 2019 - 109039
Poster only
Favorite this paper
How to cite this paper?
Abstract

Chagas disease is an endemic zoonosis in 21 countries of South and Central America, resulting from infection by the Trypanosoma cruzi parasite. Hydroxymethylnitrofural (NFOH), active against trypomastigotes and amastigotes in in vitro and in vivo tests (acute and chronic), stands out. The objective of this work was to study the effects of NFOH in vivo phase studies using bioluminescent CL Brener strain. In this protocol, during the chronic stage, the NFOH (100mg/kg) showed 100% cure of the animals, remaining unchanged after two cycles of immunosuppression. However, after the 3rd cycle, there was reactivation in two of the six animals analyzed, confirming 50% cure by the ex vivo assay. Histopathological analysis demonstrated that NFOH reduced the number of inflammatory infiltrates and cardiac fibrosis and in the hepatic tissue was able to reduce the amount of inflammatory infiltrates and total collagen values significantly different from BZN.

Track
  • 2. Medicinal Chemistry of Synthetic Compounds
Keywords
Chagas diseas
Trypanosoma cruzi
Hidroxymethynitrofurazone (NFOH)
Benznidazole
bioluminescence imaging